Insider Trading: Allergan Inc (AGN.N)

AGN.N on New York Stock Exchange

101.41USD
17 May 2013
Price Change (% chg)

$0.99 (+0.99%)
Prev Close
$100.42
Open
$100.59
Day's High
$101.43
Day's Low
$99.68
Volume
566,594
Avg. Vol
440,347
52-wk High
$116.44
52-wk Low
$81.28

Search Stocks
GALLAGHER MICHAEL R Options Exercised: 0
Trade Date: Sunday, 25 Nov 2012 Price: 91.20
Title: Director Shares Held: 36,400
Type Traded: Indirect Net Change in Shares This Filing: -28,800

Institutional Holders

% Shares Owned: 91.68%
# of Holders: 851
Total Shares Held: 271,751,771
3 Mo. Net Change: 220,117
# New Positions: 69
# Closed Positions: 44
# Increased Positions: 326
# Reduced Positions: 349
# Net Buyers: -23

Officers & Directors

Name Age Since Current Position

David Pyott

59 2011 Chairman of the Board, President, Chief Executive Officer, Principal Executive Officer

Jeffrey Edwards

52 2005 Chief Financial Officer, Principal Financial Officer, Executive Vice President - Finance and Business Development

Scott Whitcup

53 2009 Executive Vice President - Research & Development, Chief Scientific Officer

Arnold Pinkston

54 2011 Executive Vice President, General Counsel, Assistant Secretary

Scott Sherman

47 2010 Executive Vice President - Human Resources

Raymond Diradoorian

55 2006 Executive Vice President - Global Technical Operations

Douglas Ingram

50 2010 Executive Vice President and President, Europe, Africa, Middle East

James Barlow

54 2005 Senior Vice President, Corporate Controller, Principal Accounting Officer

David Endicott

48 2011 Corporate Vice President and President - Allergan Medical, Asia Pacific and Latin America

Julian Gangolli

55 2011 Corporate Vice President and President, North America

Michael Gallagher

67 2013 Lead Independent Director

Deborah Dunsire

50 2006 Independent Director

Dawn Hudson

55 2008 Independent Director

Trevor Jones

70 2004 Independent Director

Louis Lavigne

64 2005 Independent Director

Peter McDonnell

54 2013 Independent Director

Timothy Proctor

63 2013 Independent Director

Russell Ray

65 2003 Independent Director

Jim Hindman

IR Contact Officer
Search Stocks